Bruce Carleton

10.5k total citations
236 papers, 6.4k citations indexed

About

Bruce Carleton is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bruce Carleton has authored 236 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pediatrics, Perinatology and Child Health, 50 papers in Pharmacology and 34 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bruce Carleton's work include Pharmaceutical studies and practices (49 papers), Pharmacogenetics and Drug Metabolism (46 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Bruce Carleton is often cited by papers focused on Pharmaceutical studies and practices (49 papers), Pharmacogenetics and Drug Metabolism (46 papers) and Childhood Cancer Survivors' Quality of Life (19 papers). Bruce Carleton collaborates with scholars based in Canada, United States and Netherlands. Bruce Carleton's co-authors include Colin J.D. Ross, Michael R. Hayden, Michael Rieder, Mahyar Etminan, Shahrad R. Rassekh, Gideon Koren, Ursula Amstutz, Henk Visscher, Parvaz Madadi and Paul Rogers and has published in prestigious journals such as JAMA, Circulation and Nature Genetics.

In The Last Decade

Bruce Carleton

233 papers receiving 6.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bruce Carleton 2.0k 1.2k 979 904 815 236 6.4k
David W. Holt 2.1k 1.0× 584 0.5× 823 0.8× 1.1k 1.2× 1.5k 1.8× 237 8.9k
Ron H. N. van Schaik 2.2k 1.1× 2.8k 2.3× 2.7k 2.8× 2.1k 2.3× 427 0.5× 242 9.3k
D J Greenblatt 1.6k 0.8× 832 0.7× 862 0.9× 609 0.7× 887 1.1× 46 9.5k
Ron M. C. Herings 675 0.3× 283 0.2× 1.2k 1.2× 939 1.0× 1.2k 1.4× 247 8.4k
Per Damkier 633 0.3× 719 0.6× 777 0.8× 683 0.8× 259 0.3× 182 4.2k
Maryse Lapeyre‐Mestre 1.4k 0.7× 372 0.3× 299 0.3× 386 0.4× 730 0.9× 435 9.0k
Edeltraut Garbe 679 0.3× 292 0.2× 442 0.5× 414 0.5× 1.1k 1.3× 174 6.9k
Jean‐Sébastien Hulot 681 0.3× 1.1k 0.9× 900 0.9× 1.8k 2.0× 5.3k 6.5× 218 10.7k
Alexandre Pariente 420 0.2× 337 0.3× 1.2k 1.3× 719 0.8× 1.1k 1.4× 296 8.1k
Susan S. Jick 1.2k 0.6× 423 0.3× 1.7k 1.7× 2.9k 3.2× 1.4k 1.8× 321 16.9k

Countries citing papers authored by Bruce Carleton

Since Specialization
Citations

This map shows the geographic impact of Bruce Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Carleton more than expected).

Fields of papers citing papers by Bruce Carleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Carleton. The network helps show where Bruce Carleton may publish in the future.

Co-authorship network of co-authors of Bruce Carleton

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Carleton. A scholar is included among the top collaborators of Bruce Carleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Carleton. Bruce Carleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kathy H., Shahrad R. Rassekh, Bruce Carleton, et al.. (2025). Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia. Clinical Pharmacology & Therapeutics. 119(2). 447–456.
2.
Chang, Wan‐Chun, et al.. (2025). Amino Acid Stress Response Genes Contribute to a 25‐Fold Increased Risk of L‐Asparaginase–Induced Hypersensitivity. Pediatric Blood & Cancer. 72(6). e31668–e31668. 1 indexed citations
3.
Arab, Ali, Bahareh Kashani, Wan‐Chun Chang, et al.. (2024). Machine learning model identifies genetic predictors of cisplatin-induced ototoxicity in CERS6 and TLR4. Computers in Biology and Medicine. 183. 109324–109324. 5 indexed citations
4.
Bloom, David E., Simone Pecetta, Francesco Berlanda Scorza, et al.. (2024). Vaccination for healthy aging. Science Translational Medicine. 16(745). eadm9183–eadm9183. 7 indexed citations
5.
Wu, Angela, H Anderson, Curtis Hughesman, et al.. (2023). Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. Frontiers in Pharmacology. 14. 1257745–1257745. 2 indexed citations
6.
Rassekh, Shahrad R., et al.. (2023). Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity. Therapeutic Drug Monitoring. 45(3). 337–344. 9 indexed citations
7.
Brooks, Beth, Shahrad R. Rassekh, Wei Xu, et al.. (2023). Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. Therapeutic Drug Monitoring. 45(3). 345–353. 4 indexed citations
8.
Top, Karina A., Robert T. Chen, Ofer Levy, et al.. (2022). Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases. 75(Supplement_1). S11–S17. 12 indexed citations
9.
Carleton, Bruce, et al.. (2022). Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients. Pharmacogenomics. 23(5). 291–301. 5 indexed citations
10.
Sharma, Atul, Colin J.D. Ross, Bruce Carleton, et al.. (2022). Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics. Pediatric Transplantation. 27(3). e14460–e14460. 3 indexed citations
11.
Rassekh, Shahrad R., et al.. (2022). A Systematic Review of Polygenic Models for Predicting Drug Outcomes. Journal of Personalized Medicine. 12(9). 1394–1394. 10 indexed citations
12.
Elzagallaai, Abdelbaset A., et al.. (2021). DRESS induced by amoxicillin-clavulanate in two pediatric patients confirmed by lymphocyte toxicity assay. Allergy Asthma and Clinical Immunology. 17(1). 37–37. 8 indexed citations
13.
Magdy, Tarek, Mariam Jouni, Hui–Hsuan Kuo, et al.. (2021). Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. 145(4). 279–294. 59 indexed citations
14.
Lasky, Tamar, Bruce Carleton, Daniel B. Horton, et al.. (2020). Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review. Drugs - Real World Outcomes. 7(2). 97–107. 13 indexed citations
15.
Drögemöller, Britt I., Beth Brooks, Jose Gerard Monzon, et al.. (2018). Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients. Clinical Cancer Research. 24(8). 1866–1871. 28 indexed citations
16.
Carleton, Bruce, et al.. (2018). Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema. Journal of Glaucoma. 27(5). 402–406. 28 indexed citations
17.
18.
Etminan, Mahyar, Mohit Sodhi, Ali Samii, et al.. (2018). Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases. Seminars in Arthritis and Rheumatism. 48(6). 1083–1086. 14 indexed citations
19.
Kelly, Lauren E., Michael Rieder, John van den Anker, et al.. (2012). More Codeine Fatalities After Tonsillectomy in North American Children. PEDIATRICS. 129(5). e1343–e1347. 273 indexed citations
20.
Dormuth, Colin R., Greg Carney, Bruce Carleton, Ken Bassett, & James M Wright. (2009). Thiazolidinediones and Fractures in Men and Women. Archives of Internal Medicine. 169(15). 1395–1395. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W. Holt Breakdown of academic impact, for papers by Ron H. N. van Schaik Breakdown of academic impact, for papers by D J Greenblatt Breakdown of academic impact, for papers by Ron M. C. Herings Breakdown of academic impact, for papers by Per Damkier Breakdown of academic impact, for papers by Maryse Lapeyre‐Mestre Breakdown of academic impact, for papers by Edeltraut Garbe Breakdown of academic impact, for papers by Jean‐Sébastien Hulot Breakdown of academic impact, for papers by Alexandre Pariente Breakdown of academic impact, for papers by Susan S. Jick
Rankless by CCL
2026